Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Insight Partners | PRODUCT CODE: 1165345

Cover Image

PUBLISHER: The Insight Partners | PRODUCT CODE: 1165345

Asia Pacific Helicobacter Pylori Non-invasive Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Test Type, Test Method, and End User

PUBLISHED:
PAGES: 129 Pages
DELIVERY TIME: 1-5 business days
SELECT AN OPTION
PDF (Single User License)
USD 3000
PDF (Site License)
USD 4000
PDF (Enterprise License)
USD 5000

Add to Cart

The helicobacter pylori (H. pylori) non-invasive testing market in Asia Pacific is expected to grow from US$ 143.04 million in 2022 to US$ 201.37 million by 2028; it is estimated to grow at a CAGR of 5.9% from 2022 to 2028.

Spreading Awareness Among Individuals Regarding Diagnosis of H. pylori

Diagnosis of H. pylori infection is performed by invasive (endoscopy and endoscopic biopsy for histopathology, culture, and rapid urease test) and non-invasive (urea breath tests, stool antigen test, and serological tests) methods. The diagnostic decisions are based on the prevalence of H. pylori infection and age-related gastric cancer incidence. For instance, non-invasive techniques are preferred mostly where gastric cancer incidence is low. In contrast, endoscopy is recommended for patients who have a high probability of getting gastric cancer, such as patients who are above 60 years of age or younger patients in a few Asia Pacific countries, or patients with a family history of gastric cancer or geographic regions with a high incidence of gastric cancer.

For instance, the Japanese Society for Helicobacter suggests to patients that the diagnosis of H. pylori infection should be performed using at least one invasive and non-invasive method. However, increased accuracy is obtained by using multiple diagnostic tests. Although these tests have high accuracy, the endoscopy-based diagnostic methods are not recommended for screening purposes, mainly due to their invasiveness, high cost, and unavailability. Thus, the growing awareness spread by governments for proper diagnosis has led to the advent of breakthrough techniques, expected to fuel the market's growth. Further, in 2020, RedHill Biopharma launched a nationwide H. pylori disease state educational field led by its sales force. The launch is intended to provide greater awareness to healthcare professionals regarding the risk of H. pylori infection and the growing resistance of H. pylori to standard care of antibiotics, leading to 25-40% failure of current therapies.

Market Overview

Asia Pacific is the fastest-growing market for Helicobacter pylori (H. pylori) non-invasive testing. The Asia Pacific Helicobacter pylori (H. pylori) non-invasive testing market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. Asia Pacific accounted for over 22.76% of the global Helicobacter pylori (H. pylori) non-invasive testing market in 2021 due to the rising geriatric population and high prevalence of H. pylori and gastric cancer cases. Therefore, the region holds huge potential for the market players to grow during the forecast period. China is a developing country in Asia Pacific with a well-established healthcare system and a fast-growing pharmaceutical industry. China is home to various medical, pharmaceutical, and biotechnology product manufacturing companies operating in the global market. These pharmaceuticals and biotechnology companies are involved in the development of various testing kits and devices for the dectection of Helicobacter pylori owing to the high prevalence of various H. pylori infections and gastric (stomach) cancer cases, which boosts the growth of the Helicobacter pylori non-invasive testing market.

The rising geriatric population is expected to offer vital growth opportunities for the Helicobacter pylori (H. pylori) non-invasive testing market in the coming years. However, the prevalence of Helicobacter pylori infection is significant in all ages; however, the geriatric population is likely to diagnose with gastric cancer and infections that can lead to serious illness and other medical emergencies. According to World Health Organization, in China, in 2019, there were ~254 million people of age 60 and older and ~176 million people of age 65 and over. It is estimated that ~402 million people (28% of the total population) in China will be over the age of 60 by 2040, which will create an opportunity for the use of various H. pylori testing kits, leading to the market growth in the coming years.

Asia Pacific Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Helicobacter Pylori (H. pylori) Non-invasive Testing Market Segmentation

The Asia Pacific helicobacter pylori (H. pylori) non-invasive testing market is segmented on test type, test method, end user, and country.

Based on test type, the Asia Pacific Helicobacter pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breathe. In 2022, the urea breath segment is expected to hold the largest share of the market. Based on test method, the Asia Pacific Helicobacter pylori (H. pylori) non-invasive testing market is bifurcated into laboratory based and point of care. The laboratory based segment is expected to hold a larger share of the market in 2022. Based on end user, the Asia Pacific Helicobacter pylori (H. pylori) non-invasive testing market is segmented into hospitals, clinics, and diagnostic laboratories. The diagnostic laboratories segment is expected to hold the largest share of the market in 2022. Based on country, the Asia Pacific Helicobacter pylori (H. pylori) non-invasive testing market is segmented into Australia, China, India, Japan, South Korea, the Rest of Asia Pacific. Further, China dominated the market in 2022. Abbott Laboratories; Bio-Rad Laboratories Inc.; CerTest Biotec; Coris BioConcept; DiaSorin S.p.A.; Meridian Bioscience Inc.; QuidelOrtho Corporation; Sekisui Diagnostics; Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd; and Thermo Fisher Scientific Inc. are the leading companies operating in the helicobacter pylori (H. pylori) non-invasive testing market in Asia Pacific.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific helicobacter pylori (H. pylori) non-invasive testing market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific helicobacter pylori (H. pylori) non-invasive testing market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the helicobacter pylori (H. pylori) non-invasive testing market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Product Code: BMIRE00027537

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 APAC Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - By Test Type
    • 1.3.2 APAC Helicobacter Pylori (H. pylori) Non-invasive Testing Market - By Test Method
    • 1.3.3 APAC Helicobacter Pylori (H. pylori) Non-invasive Testing Market - By End User
    • 1.3.4 APAC Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. APAC Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Market Landscape

  • 4.1 Overview
  • 4.2 APAC PEST Analysis
  • 4.3 Experts Opinion

5. APAC Helicobacter Pylori (H. pylori ) Non-Invasive Testing Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing prevalence of H. pylori bacterial infection
    • 5.1.2 New Product Launches & FDA Approvals for Noninvasive Tests
    • 5.1.3 Spreading Awareness Among Individuals Regarding Diagnosis of H. pylori
    • 5.1.4 Rise in Investments by Pharmaceutical Companies
  • 5.2 Key Market Restraints
    • 5.2.1 Low Diagnosis Rate
  • 5.3 Key Market Opportunities
    • 5.3.1 Increasing Number of Conferences and Events for Research
    • 5.3.2 Introduction of Artificial Intelligence
  • 5.4 Future Trends
    • 5.4.1 Increasing Use of Home-Based POC Devices
    • 5.4.2 Diagnosis for Resistance
  • 5.5 Impact Analysis

6. Helicobacter pylori (H. pylori ) Non-Invasive Testing Market- APAC Analysis

  • 6.1 APAC Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue Forecast and Analysis

7. APAC Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Analysis- by Test Type

  • 7.1 Overview
  • 7.2 APAC Helicobacter pylori (H. pylori ) Non-invasive Testing Market, By Test Type 2022 & 2028 (%)
  • 7.3 Serology Test
    • 7.3.1 Overview
    • 7.3.2 APAC Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)
  • 7.4 Stool Antigen Test
    • 7.4.1 Overview
    • 7.4.2 APAC Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)
  • 7.5 Urea Breath Test
    • 7.5.1 Overview
    • 7.5.2 APAC Urea Breath Test Market Revenue and Forecasts to 2028 (US$ Mn)

8. APAC Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Analysis- by Test Method

  • 8.1 Overview
  • 8.2 APAC Helicobacter pylori (H. pylori) Non-invasive Testing Market, By Test Method 2022 & 2028 (%)
  • 8.3 Laboratory Based Tests
    • 8.3.1 Overview
    • 8.3.2 APAC Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)
  • 8.4 Point Of Care Tests
    • 8.4.1 Overview
    • 8.4.2 APAC Point of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)

9. APAC Helicobacter pylori (H. pylori ) Non-invasive Testing Market Analysis- by End User

  • 9.1 Overview
  • 9.2 APAC Helicobacter pylori (H. pylori ) Non-invasive Testing Market, By End User 2018 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 APAC Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
  • 9.4 Clinics
    • 9.4.1 Overview
    • 9.4.2 APAC Clinics Market Revenue and Forecasts to 2028 (US$ Mn)
  • 9.5 Diagnostic Laboratories
    • 9.5.1 Overview
    • 9.5.2 APAC Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

10. APAC Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028 - Country Analysis

  • 10.1 Overview
    • 10.1.1 Asia Pacific: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028, By Country, 2022 & 2028 (%)
      • 10.1.1.1 China: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 China: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.1.1.1.3 China: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
        • 10.1.1.1.4 China: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
        • 10.1.1.1.5 China: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
      • 10.1.1.2 Japan: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Japan: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.1.1.2.3 Japan: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
        • 10.1.1.2.4 Japan: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
        • 10.1.1.2.5 Japan: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
      • 10.1.1.3 India Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 India: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.1.1.3.3 India: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
        • 10.1.1.3.4 India: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
        • 10.1.1.3.5 India: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
      • 10.1.1.4 South Korea: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 South Korea: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.1.1.4.3 South Korea: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
        • 10.1.1.4.4 South Korea: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
        • 10.1.1.4.5 South Korea: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
      • 10.1.1.5 Australia: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Australia: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
        • 10.1.1.5.3 Australia: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
        • 10.1.1.5.4 Australia: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
        • 10.1.1.5.5 Australia: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
      • 10.1.1.6 Rest of Asia Pacific: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Asia Pacific: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.3 Rest of Asia Pacific: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
        • 10.1.1.6.4 Rest of Asia Pacific: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
        • 10.1.1.6.5 Rest of Asia Pacific: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)

11. Helicobacter Pylori (H. Pylori ) Non-Invasive Testing Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Helicobacter Pylori (H. Pylori ) Non-Invasive Testing Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profile

  • 12.1 DiaSorin S.p.A.
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Meridian Bioscience, Inc.
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 QuidelOrtho Corporation
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Abbott Laboratories
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Thermo Fisher Scientific Inc.
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 CerTest Biotec
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Sekisui Diagnostics
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Coris BioConcept
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Bio-Rad Laboratories, Inc.
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms
Product Code: BMIRE00027537

List Of Tables

  • Table 1. China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million).
  • Table 2. China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million).
  • Table 5. Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million).
  • Table 8. India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million).
  • Table 11. South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million).
  • Table 14. Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million).
  • Table 17. Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Recent Inorganic Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market
  • Table 20. Recent Organic Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market
  • Table 21. Glossary of Terms

List Of Figures

  • Figure 1. APAC Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Segmentation
  • Figure 2. APAC Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, By Country
  • Figure 3. APAC Helicobacter Pylori (H. pylori) Non-invasive Testing Market Overview
  • Figure 4. Urea Breath Segment Held Largest Share of Test Type Segment in APAC Helicobacter Pylori (H. pylori) Non-invasive Testing Market
  • Figure 5. Australia is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. APAC: PEST Analysis
  • Figure 7. Experts Opinion
  • Figure 8. APAC Helicobacter pylori Non-Invasive Testing Market Impact Analysis of Driver and Restraints
  • Figure 9. APAC Helicobacter pylori (H. pylori) Non-Invasive Testing Market- Revenue Forecast and Analysis - 2020 - 2028
  • Figure 10. APAC Helicobacter pylori (H. pylori) Noninvasive Testing Market, by Test Type 2022 & 2028 (%)
  • Figure 11. APAC Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 12. APAC Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 13. APAC Urea Breath Test Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 14. APAC Helicobacter pylori (H. pylori) Noninvasive Testing Market, by Test Method 2022 & 2028 (%)
  • Figure 15. APAC Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 16. APAC Point of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 17. APAC Helicobacter pylori (H. pylori) Noninvasive Testing Market, by End User 2018 & 2028 (%)
  • Figure 18. APAC Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 19. APAC Clinics Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 20. APAC Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 21. Asia Pacific Helicobacter pylori (H. pylori) Non-Invasive Testing Market Overview, by Country (2022)
  • Figure 22. Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028, By Country, 2022 & 2028 (%)
  • Figure 23. China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 24. apan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 25. India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 26. South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 27. Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 28. Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!